• Nichi-Iko®
  • Serialization/Track and Trace
  • Investors
  • Careers
  • Anti-Capital Punishment Statement
  • Contact Us
  • sagentbiosimilars.com
  • zoledronicpremix.com
  • glydo.com
Sagent PharmaceuticalsSagent Pharmaceuticals
Sagent Pharmaceuticals
  • Home
  • About
    • Our Executive Team
    • Who We Are
    • What We Do
    • Why We Do It
  • Products
  • PreventIV Measures®
Home > LEVETIRACETAM Injection, USP Recall Information

Sagent

1.LEVETIRACETAM Injection, USP Recall Information
2.PHENYLEPHRINE HCl Injection, USP Recall Information
3.We’re thrilled to keep in touch
4.Anti-Capital Punishment Statement
5.Nichi-Iko Pharmaceutical Co., Ltd to Acquire Sagent Pharmaceuticals for $21.75 Per Share in All Cash Transaction
6.OXACILLIN for Injection, USP Recall Information
7.OXACILLIN for Injection, USP Recall Information
8.FLUCONAZOLE Injection, USP in 0.9% Sodium Chloride Recall Information
Total 8 result(s) found. Search for [] with Google
www.SagentPharma.com Site Map Privacy Terms of Use for Site(s) Sales Terms & Conditions

The SAGENT logo, SAGENT, SAGENT Pharmaceuticals and PreventIV Measures are registered trademarks of Sagent Pharmaceuticals, Inc.
The Nichi-Iko logo, NICHI-IKO and NIKP are registered trademarks of Nichi-Iko Pharmaceutical Co., Ltd.
© 2022 Sagent Pharmaceuticals, Inc.